Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D to Reduce Chronic Pain After Burn Injury
NCT05619289Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Apr 2023
- Primary completion
- Jan 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic pain comparing Vitamin D2 (Ergocalciferol) with Placebo (2 arms). Primary endpoint: Follow-up rate 6 weeks following burn injury. Started Apr 2023; status: completed.
02
Drugs
vitamin d
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT05619289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05619289.